Haemostatix Ltd.

ACTIVE

United Kingdomwww.haemostatix.comSubsidiary11–50 employeesEstablished: 2003-01-01

Part of Ergomed Plc

Clinical Trials

3 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

2003

Overview

Trial Phase Distribution

Phase

Trials

Phase 1

80.0%

Phase 2

20.0%

Trial Status Distribution

Active, not recruiting

60.0%

Completed

40.0%

Clinical Trials

Trials sponsored by this organization (5)

A study to evaluate the effectiveness and safety of study drug (PeproStat) to stop bleeding during surgery.

Phase 1

Active, not recruiting

Jun 2017300 participants

PeproStat as a Topical Agent Used to Stop Bleeding in Patients Undergoing Surgery

Phase 2

Completed

interventional

Mar 2017169 participants

A study to evaluate the effectiveness and safety of study drug (PeproStat) to stop bleeding during surgery.

Phase 1

Active, not recruiting

Jan 2017300 participants

A study to evaluate the effectiveness and safety of study drug (PeproStat) to stop bleeding during surgery.

Phase 1

Active, not recruiting

Dec 2016214 participants

PeproStat Haemostat Study in Subjects Undergoing Liver Surgery

Phase 1

Completed

interventional

Jul 201420 participants

Approvals

No approval data available

News

No news articles found

Back to Organizations